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Abstract
Background: Approach system considered a motivational system that activates reward-seeking behavior is associated with 
exploration/impulsivity, whereas avoidance system considered an attentional system that promotes inhibition of appetitive 
responses is associated with active overt withdrawal. Approach and avoidance dispositions are modulated by distinct 
neurochemical profiles and synaptic patterns. However, the precise working of neurons and trafficking of molecules in the 
brain activity predisposing to approach and avoidance are yet unclear.
Methods: In 3 phenotypes of inbred mice, avoiding, balancing, and approaching mice, selected by using the Approach/
Avoidance Y-maze, we analyzed endogenous brain levels of brain derived neurotrophic factor, one of the main secretory 
proteins with pleiotropic action. To verify the effects of the acute increase of brain derived neurotrophic factor, balancing and 
avoiding mice were bilaterally brain derived neurotrophic factor-infused in the cortical cerebellar regions.
Results: Approaching animals showed high levels of explorative behavior and response to novelty and exhibited higher brain 
derived neurotrophic factor levels in the cerebellar structures in comparison to the other 2 phenotypes of mice. Interestingly, 
brain derived neurotrophic factor-infused balancing and avoiding mice significantly increased their explorative behavior and 
response to novelty.
Conclusions: Cerebellar brain derived neurotrophic factor may play a role in explorative and novelty-seeking responses that 
sustain the approach predisposition.
Keywords: approach-avoidance behavior, brain derived neurotrophic factor, cerebellar infusion, individual differences, 
open field task
Introduction
Novelty- and reward-seeking behavior associated with explor-
ation is typical of the motivational approach system, whereas 
appetitive response inhibition and active withdrawal are 
representative of the attentional avoidance system (McNaughton 
and Gray, 2000; Pickering and Gray, 2001; Carver and Miller, 2006). 
Within the same species, some individuals have an overt ten-
dency toward positive (e.g., rewarding) or away from negative 
(e.g., dangerous) stimuli, neophilic or neophobic responses, 
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exploratory or withdrawal behaviors (Greenberg, 2003; 
Laricchiuta and Petrosini, 2014; Laricchiuta, 2015). Thus, indi-
vidual differences in approach and avoidance may be consid-
ered constitutionally ingrained stable traits (Elliot, 2005, 2008; 
Sullivan et al., 2008; Helfinstein et al., 2011).
Approach and avoidance predispositions emerge from mech-
anisms operative in the whole brain, from spinal cord (Schutter 
et  al., 2011) to brainstem (Nelson and Panksepp, 1998; Challis 
et al., 2013), to cortical regions (Nasser and McNally, 2012). Even 
if it is known that the intensity of the appetitive or defensive 
behavior is modulated by the levels of specific neurotransmit-
ters and neuromodulators (Berridge, 2000; Linfoot et  al., 2009; 
Groppe et al., 2013; Mogi et al., 2014), the precise working of neu-
rons and trafficking of molecules in determining approach and 
avoidance patterns are yet unclear.
In an attempt to clarify this issue, we selected 3 phenotypes 
of inbred mice that spontaneously react to conflicting (simultane-
ously rewarding and threating) stimuli with withdrawing (avoiding 
[AV] mice), balanced (balancing [BA] mice), or advancing (approach-
ing [AP] mice) responses (Laricchiuta et  al., 2012a, 2012b, 2014a, 
2016). The presynaptic control of cannabinoid type-1 (CB1) recep-
tors on GABAergic transmission in the dorsostriatal medium spiny 
neurons is nearly absent in the AV mice and conversely markedly 
increased in the AP mice in comparison with BA mice (Laricchiuta 
et al., 2012b). Further, when compared with BA animals, both AP 
and AV animals have greater CB1 receptor density in the amygda-
loid nuclei and ventromedial hypothalamic nucleus, and only AP 
animals have also higher CB1 receptor functionality in the amyg-
daloid nuclei and dorsomedial hypothalamic nucleus (Laricchiuta 
et al., 2012a). Evidence suggests that density and functionality of 
CB1 receptors in the corticolimbic, striatal, and cerebellar areas cor-
relate with the levels of brain derived neurotrophic factor (BDNF), 
an activity-regulated secretory protein with pleiotropic action 
widely expressed within the previously quoted areas. In fact, BDNF 
brain levels are lower in mice lacking CB1 receptors (Aso et al., 2008), 
whereas CB1 activation increases BDNF levels in rodents (Butovsky 
et al., 2005) and humans (D’Souza et al., 2009). The increased BDNF 
release triggered by CB1 stimulation mediates in turn the neuro-
protective effects of endocannabinoids (Khaspekov et  al., 2004). 
The mutant DISC1 mice, model of schizophrenia-like endopheno-
type, display impaired preference for social novelty, reduced BDNF 
receptor levels in prefrontal cortex, and diminished CB1 expression 
in hippocampus (Kaminitz et al., 2014). BDNF inhibits CB1 response 
in the visual cortex (Huang et al., 2008) and increases the expres-
sion of CB1 receptor transcripts in cultured cerebellar granule 
neurons (Maison et al., 2009). However, striatal BDNF inhibits CB1 
functionality, and this interplay crucially controls the emotional 
consequences of stressful or rewarding experiences (Berton et al., 
2006; De Chiara et  al., 2010). Furthermore, prolonged exposure 
to palatable food suppresses CB1 receptor gene expression and 
reduces BDNF levels (Martire et al., 2014). Interestingly, adult off-
spring of dams treated with corticosterone and fed a tryptophan-
deficient diet show increased avoidance behaviors and anhedonia 
toward highly palatable reward, reduced striatal and increased 
hypothalamic BDNF levels, and reduced dopamine and serotonin 
levels in prefrontal cortex (Zoratto et al., 2013).
Starting from BDNF’s role as CB1 mediator and from obser-
vation that endocannabinoid activity is linked to the individual 
differences in approach and avoidance stable predispositions 
(Laricchiuta et al., 2012a, 2012b), it is possible to hypothesize that 
the difference in basal BDNF levels can represent a neurobiologi-
cal marker of individual differences in approach and avoidance 
enduring tendencies. Thus, the present research firstly analyzed 
the endogenous BDNF levels in the 3 AV, BA, and AP phenotypes 
of mice in frontal cortex, hippocampus, striatum, and cerebel-
lum, regions involved in approach and avoidance stable traits 
(Laricchiuta et al., 2012a, 2012b; Picerni et al., 2013; Laricchiuta 
et al., 2014a, 2014b, 2014c, 2016) and expressing high BDNF levels 
(Angelucci et al., 2009; De Chiara et al., 2010; Caporali et al., 2014; 
Cutuli et al., 2015). The present results indicate that in compari-
son with AV and BA mice, AP mice showed higher BDNF levels 
only in the cerebellum. Subsequently, we thus performed bilat-
eral BDNF infusions in the cerebellar cortical regions to inves-
tigate whether even acutely increased cerebellar BDNF levels 
promoted explorative and novelty-seeking responses, typical 
components of the approach predisposition.
Methods
Subjects and Experimental Procedure
Male C57BL/6JOlaHsd mice (n = 198; 40 d old at study onset) (Envigo) 
were housed 4 per cage, with food (Mucedola) and water ad libi-
tum. The mice were kept under a 12-h-light/-dark cycle, controlled 
temperature (22°C–23°C), and constant humidity (60% ± 5%). All 
efforts were made to minimize animal suffering and reduce the 
number of animals used, per the European Directive (2010/63/EU).
The timeline of the experimental procedure is reported in 
Figure 1. Based on the distribution of responses in the Approach/
Avoidance (A/A) Y-maze, we selected AV (n = 5), BA (n = 5), and AP 
(n = 5) animals. After 2 weeks, the animals were tested in the 
open field with novel object (OFo) task. To analyze the BDNF role 
in approach and avoidance stable dispositions, 2 weeks later the 
animals were killed to determine endogenous BDNF brain levels.
Two weeks after the A/A Y-Maze, other AV (n = 8) and BA (n = 36) 
mice were bilaterally implanted with guide cannulas into the 
cerebellar cortical regions. Twenty-four hours later, the AV and 
BA (n = 21 of 36) animals were injected with phosphate-buffered 
saline (PBS) (group names: BA-PBS, n = 7; AV-PBS, n = 4) or 0.25 μg/μL 
PBS/side BDNF (group name: BA-BDNF 0.25, n = 7) or 0.75 μg/μL 
PBS/side BDNF (group names: BA-BDNF 0.75, n = 7; AV-BDNF 0.75, 
n = 4). Two hours later, all animals performed the OFo task.
Seventy-two hours after cannula implantations, the remain-
ing BA (n = 15) mice were injected with PBS (n = 5) or 0.25 (n = 5) or 
0.75 (n = 5) μg/μL PBS/side BDNF. In parallel, the AV mice were re-
injected with PBS or 0.75 μg/μL PBS/side BDNF. Two hours later, 
all animals were re-tested in the A/A Y-Maze.
Significance Statement
The present research deals with the neurobiological basis of individual differences, in particular the predispositions in approach 
and avoidance. The findings indicated that the individual differences in the inherent predisposition to approach were associ-
ated with the basal cerebellar brain derived neurotrophic factor (BDNF) levels, and that the cerebellar BDNF levels were causally 
related with the acute response of approach in its double component of exploration and search for novelty. Here, we are pro-
posing that the basal endogenous or acutely increased cerebellar BDNF levels promote explorative response and searching for 
novelty, components that sustain the approach pattern.
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To perform histological control of BDNF injection sites and 
diffusion, the mice infused with PBS or BDNF were injected with 
1 μL/side of PBS containing methylene blue, and 2 h later they 
were killed by decapitation (supplementary Methods; Figure 2).
Behavioral Testing
A/A Y-Maze
The test implemented to select approach/avoidance phenotypes 
has been previously described (Laricchiuta et al., 2012a, 2014a, 
2014b, 2016) and is accurately detailed in the supplementary 
Methods. The apparatus consisted of a Y-maze with a starting 
gray arm and 2 choice arms: 1 black and dark, the other one 
white and lit.
In Session 1 (S1), the slightly food-deprived animal could 
choose to enter one of the 2 arms, both containing the same 
standard food reward. During Session 2 (S2), which started 24 h 
after S1, the white arm was rewarded with a new palatable food 
(Fonzies, KP Snack Foods) (Bassareo et al., 2002), while the black 
arm remained rewarded with the standard food. Notably, the 
S2 of A/A test required to choose between 2 conflicting drives: 
reaching the new palatable reward placed in an aversive (white 
and lighted) environment or reaching the familiar standard 
food placed in a reassuring (black and dark) environment. The 
slightly food-deprived animals to be re-tested were submitted 
to a new session (S3) applying the S2 protocol (Laricchiuta et al., 
2012b, 2014a).
The parameters considered were: white choices, frequency 
of entry into the white arm in S1, S2, and S3; A/A conflict index, 
Figure 1. Timeline of the experimental procedure. (A) Avoiding (AV, n = 5), balancing (BA, n = 5), and approaching (AP, n = 5) mice were selected based on the distribution 
of responses in the session 1 (S1) and session 2 (S2) of the Approach/Avoidance (A/A) Y-maze. Two weeks later, the animals were tested in the Open Field with novel 
object (OFo) task. Two weeks later the animals were killed to determine endogenous BDNF brain levels through enzyme-linked immunosorbent assay procedure. (B) 
Other BA (n = 36) mice were bilaterally implanted with guide cannulas into the cerebellar cortical regions. Twenty-four hours later, 21 of 36 BA animals were injected 
with PBS (BA-PBS, n = 7), 0.25 μg/μL PBS/side BDNF (BA-BDNF 0.25, n = 7), or 0.75 μg/μL PBS/side BDNF (BA-BDNF 0.75, n = 7). Two hours later, the animals performed the 
OFo task. Seventy-two hours after cannula implantations, the remaining 15 BA mice were injected with PBS (n = 5) or 0.25 (n = 5) or 0.75 (n = 5) μg/μL PBS/side BDNF. Two 
hours later, the animals were retested in session 3 (S3) of A/A Y-Maze. All BA (n = 36) infused animals were injected with 1 μL/side of PBS containing methylene blue to 
perform histological control of BDNF injection sites and diffusion. Two hours later, they were killed by decapitation. (C) Other AV (n = 8) mice were bilaterally implanted 
with guide cannulas into the cerebellar cortical regions. Twenty-four hours later, they were injected with PBS (AV-PBS, n = 4), or 0.75 μg/μL PBS/side BDNF (AV-BDNF 
0.75, n = 4). Two hours later, the animals performed the OFo task. Forty-eight hours later, the AV mice were re-injected with PBS or BDNF. Two hours later, the animals 
were retested in A/A Y-Maze S3. The AV infused-animals were injected with 1 μL/side of PBS containing methylene blue and 2 h later they were killed by decapitation.
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the difference in the number of white choices between S2 and 
S1. Given that this index was normally distributed, it allowed 
us to identify the 3 AV, BA, and AP phenotypes. In particular, BA 
animals (22% of mice) showed values in the A/A conflict index 
corresponding to the mean of the distribution. The 2 tails of the 
distribution curve represented the few subjects that exhibited 
responses unbalanced toward one of the conflicting inputs: AV 
animals (7% of mice) had A/A conflict index values correspond-
ing to -2 SDs of the mean, while AP animals (6% of mice) had 
values corresponding to + 2 SDs of the mean.
OFo Task
To eliminate the “food” and “palatability” dimensions and main-
tain the conflicting drives given by an appealing new object placed 
in an anxiogenic central location of a wide arena, the OFo task 
(detailed in the supplementary Methods) was used (Laricchiuta 
et al., 2012b, 2014a). In S1 the animal was allowed to explore an 
empty 60-cm circular arena, while in S2 an object (a gray plas-
tic cone: 10 × 6 cm; base diameter :  9.5 cm) was put in the arena 
center. Notably, the approach to the object requires the subject to 
overcome its innate fear toward open spaces and indicates thus 
that the animal is reacting to the mismatch between the initial 
(empty arena) and new (presence of the object) situations.
The parameters considered were: total distance (in cm) 
traveled in the arena in each session; peripheral distance, the 
percentage of total distance traveled in a 6-cm peripheral annu-
lus in each session; central distance, the percentage of total dis-
tance traveled in a central circular area (diameter 21.5  cm) in 
each session; mean velocity in each session; contact time with 
the object.
BDNF Determination
Tissue Dissection
The AV, BA, and AP mice (n = 5/group) were decapitated, and the 
brains were removed and dissected on ice using a binocular dis-
section microscope. Frontal cortex, hippocampus, striatum, and 
cerebellum were bilaterally collected according to Glowinski 
and Iversen’s method (1966). All regions were extracted in 1 mL 
extraction buffer/100  mg tissue. Brain tissue samples were 
homogenized in an ice-cold lysis buffer containing 137  mM 
NaCl, 20  mM Tris-HCl (pH 8.0), 1% NP40, 10% glycerol, 1  mM 
phenylmethanesulfonylfluoride, 10 mg/mL aprotinin, 1 mg/mL 
leupetin, and 0.5 mM sodium vanadate. The tissue homogenate 
solutions were centrifuged at 14 000g for 25 minutes at 4°C. The 
supernatants were collected and stored at -80°C until analysis 
for quantification of BDNF.
Enzyme-Linked Immunosorbent Assay
BDNF concentrations were assessed using a 2-site enzyme 
immunoassay kit (G7610 Promega). In brief, 96-well immuno-
plates (NUNC) were coated with 50 μL/well with the correspond-
ing capture antibody and stored overnight at 4°C. The next day, 
serial dilutions of known amounts of BDNF ranging from 0 to 
500 pg/mL were performed in duplicate to generate a standard 
curve. The plates were washed 3 times with wash buffer, and 
the standard curves and supernatants of brain tissue homogen-
ates were incubated in the coated wells (100 μL each) for 2 h at 
room temperature (RT) with shaking. After additional washes, 
the antigen was incubated with second specific antibody for 2 h 
Figure 2. Histological control of bilateral brain derived neurotrophic factor (BDNF) injection sites and diffusion in the cerebellar cortex. A representative photomicro-
graph (2x magnification) showing the left methylene blue injection site and the cerebellar cortical diffusion is superimposed to a drawing adapted from Franklin and 
Paxinos (1997). Abbreviations: Med, medial (fastigial) cerebellar nucleus; Int, interpositus cerebellar nucleus; IntA, interpositus cerebellar nucleus, anterior; Lat, lateral 
(dentate) cerebellar nucleus; LatPC, lateral cerebellar nucleus, parvicellular; PFl, paraflocculus; Fl, flocculus; MVePC, medial vestibular nucleus, parvicellular; MVeMC, 
medial vestibular nucleus, magnocellular; LVe, lateral vestibular nucleus; SpVe, spinal vestibular nucleus; DC, dorsal cochlear nucleus; 7N, facial nucleus.
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at RT. The plates were washed again with wash buffer and then 
incubated with an anti-IgY HRP for 1 h at RT. After another wash, 
the plates were incubated with a TMB/peroxidase substrate 
solution for 15 min and phosphoric acid 1 M (100 μL/well) was 
added to the wells. The colorimetric reaction product was meas-
ured at 450 nm using a microplate reader (Dynatech MR 5000). 
BDNF concentrations were determined from the regression line 
for the BDNF standard (ranging from 7.8 to 500 pg/mL-purified 
mice BDNF) incubated under similar conditions in each assay. 
As declared by the company (Promega), the cross-reactivity with 
other related neurotrophic factors (NGF, NT-3, and NT-4) was 
<3%. BDNF concentration was expressed as pg/g wet weight. All 
assays were performed in triplicate.
Cerebellar BDNF Infusion
Mice were anesthetized by using Zoletil 100 (tiletamine HCl 
50  mg/mL + zolazepam HCl 50  mg/mL; Virbac) and Rompun 
20 (xylazine 20  mg/mL; Bayer S.p.A) dissolved in a volume of 
4.1 mg/mL and 1.6 mg/mL, respectively, in saline and i.p. injected 
in a volume of 7.3  mL/kg. Mice were mounted onto a stereo-
taxic frame (David Kopf Instruments) equipped with a mouse 
adapter and bilaterally implanted with guide cannulas (stain-
less steel, shaft outer diameter 0.38 mm, Metalant AB) lowered 
0.3 mm from the scalp in cerebellar cortical regions. The coordi-
nates from bregma, measured according to the atlas of Franklin 
and Paxinos (1997) and Mouse Brain Atlases (The Mouse Brain 
Library, www.nervenet.org), were: AP -6.1; L ±2.2. The guide 
cannulas were fixed with epoxy glue and dental cement. The 
length of the guide cannulas was 4.5  mm. Twenty-four hours 
after the guide cannula implantations, the infusion cannulas 
(diameter 0.25 mm; Unimed) were bilaterally inserted into the 
guide cannulas, so that 0.6 mm of the infusion cannula extended 
past the end of the guide cannula. According to Saylor and 
McGinty (2010), human recombinant BDNF (Tocris Bioscience, R 
& D Systems) at 2 concentrations (0.25 or 0.75 μg/μL PBS/side) 
or sterile PBS was infused into cerebellar regions by using 10-μL 
Hamilton syringes and an infusion pump (Harvard Apparatus). 
Volumes of 1 μL/side of BDNF or PBS were infused over 5 min, 
and the infusion cannulas remained in the guide cannulas for 
5 min before and after the infusion. Two hours later, mice were 
submitted to behavioral testing.
Statistical Analysis
Data presented as mean ± SEM were tested for normality (Will-
Shapiro’s test) and homoscedasticity (Levene’s test). Behavioral and 
neurochemical data were compared by using ANOVAs, followed 
by Tukey’s HSD test when appropriate. When data did not fully 
meet parametric assumptions, nonparametric analyses (Friedman 
ANOVA, Wilcoxon Signed Rank Test, and Mann–Whitney U) were 
used. Linear regression analyses were run to determine the asso-
ciations between cerebellar BDNF levels and A/A conflict index and 
white choices in the S2 of A/A Y-Maze, or distances, velocity, and 
contact time with the novel object in the OFo task sessions. The 
differences were considered significant at the P < .05 level.
Figure 3. Approach/Avoidance (A/A) Y-Maze performances of avoiding (AV), balancing (BA), and approaching (AP) mice. (A) The curve of distribution of the A/A conflict 
index (the difference [Δ] in the number of white choices between session 2 [S2] and 1 [S1]) indicates that the white choice frequency increased (mean =  Δ + 1). (B) The 
white choices were similar among phenotypes in S1, while AV mice showed the lowest number of white choices (***P = .0002), and BA mice showed a number of white 
choices lower than AP mice (***P = .0002) in S2. Between S1 and S2, the number of white choices within groups was different (***P = .0002), given that it decreased in the 
AV mice and increased in the BA and AP mice. In B, data are presented as means ± SEM.
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Results
A/A Y-Maze Performances of AV, BA, and AP Mice
The A/A conflict index was normally distributed (Figure  3A), 
and its bell-shaped curve indicated that in S2 the new palatable 
food, even if placed in the aversive white environment, was sali-
ent enough to increase white choices number.
When white choices in S1 and S2 were analyzed in relation to 
the phenotype of the animals (Figure 3B), a 2-way ANOVA (phe-
notype x session) revealed significant phenotype (F2,12 = 12.93, 
P = .001) and session (F1,12 = 14.3, P = .001) effects. The interaction 
was significant (F2,12 = 42.0, P = .0001). Posthoc comparisons on 
interaction revealed no significant differences in S1 among AV, 
BA, and AP mice. In S2, while AV mice showed the lowest num-
ber of white choices (always P = .0002), BA mice showed a num-
ber of white choices lower than AP mice (P = .0002). Between S1 
and S2, the number of white choices was significantly different 
(always P = .0002) in the 3 phenotypes, given that it decreased in 
the AV mice and increased in the BA and AP mice.
OFo Performances of AV, BA, and AP Mice
AP mice were significantly more active and explorative than AV 
and BA animals. Two-way ANOVA (phenotype × session) on total 
distances (Figure  4A) revealed a significant phenotype effect 
(F2,12 = 8.82, P = .004), while session effect (F1,12 = 2.67, P = .13) and 
interaction (F2,12 = 3.19, P = .08) were not significant. Posthoc com-
parisons on phenotype effect revealed that AP animals explored 
the environment more actively than BA (P = .003) and AV (P = .05) 
animals. Two-way ANOVA (phenotype × session) on peripheral 
distances (Figure  4B) revealed no significant phenotype effect 
(F2,12 = 1.30, P = .31), while session effect (F1,12 = 1 87.66, P < .00001) was 
significant. Interaction (F2,12 = 1.43, P = .28) was not significant. Two-
way ANOVA (phenotype × session) on central distances (mean ± SE: 
AV: S1 12.5 ± 1.9, S2 41.0 ± 5.0; BA: S1 10.5 ± 2.5, S2 49.8 ± 2.9; AP: 
S1 13.7 ± 3.7, S2 47.6 ± 2.3) showed no significant phenotype effect 
(F2,12 = 1.39, P = .29), while session effect (F1,12 = 1 94.62, P < .00001) 
was significant. Interaction (F2,12 = 1.66, P = .23) was not significant. 
Two-way ANOVA (phenotype × session) on velocity (Figure  4C) 
revealed a significant phenotype effect (F2,12 = 8.88, P = .004), while 
session effect (F1,12 = 2.70, P = .13) and interaction (F2,12 = 3.31, P = .07) 
were not significant. Posthoc comparisons on phenotype effect 
revealed that AP animals were more rapid than BA (P = .003) and 
AV (P = .05) animals. One-way ANOVA on contact time with the 
novel object (Figure 4D) revealed a significant phenotype effect 
(F2,12 = 15.46, P = .0005). In fact, the AP animals contacted the novel 
object longer than BA (P = .003) and AV (P = .007) animals.
Brain BDNF Determination in AV, BA, and AP Mice
One-way ANOVA on BDNF levels in the cerebellum revealed a 
significant phenotype effect (F2,12 = 6.64, P = .01). Posthoc com-
parisons revealed that AP animals exhibited the highest BDNF 
Figure 4. Open Field with object (OFo) performances of avoiding (AV), balancing (BA), and approaching (AP) mice. Total distances (A), peripheral distances (B), and veloc-
ity (C) in session 1 (S1) and 2 (S2) are reported. Peripheral distances (B) decreased between S1 and S2 (***P = .001). AP animals were more active and rapid in exploring the 
environment (A, C), and contacted the novel object (D) longer than BA (**P = .003) and AV (*P = .007) animals. Data are presented as means ± SEM.
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cerebellar levels (AP vs BA: P = .05; AP vs AV: P = .01; BA vs AV: 
P = .73) (Figure  5A). Conversely, 1-way ANOVAs on BDNF levels 
in the frontal cortex (F2,12 = 1.63, P = .24), hippocampus (F2,12 = 1.13, 
P = .35), and striatum (F2,12 = 0.38, P = .69) failed to reveal any sig-
nificant difference among the 3 phenotypes (Figure 5B-D).
Linear Regressions between Cerebellar BDNF Levels 
and Behavioral Data in AV, BA, and AP Mice
Positive significant associations were found between cerebellar 
BDNF levels and A/A conflict index (ß = 0.69, F1,14 = 12.03, P = .0041), 
number of white choices in the S2 of the A/A Y-Maze (ß = 0.59, 
F1,14 = 6.89, P = .02), and contact times with the novel object 
(ß = 0.61, F1,14 = 7.83, P = .01) in the OFo task (Figure 6A-C). No sig-
nificant associations were found between cerebellar BDNF lev-
els and total (S1: ß = 0.47, F1,14 = 3.65, P = .08; S2: ß = 0.21, F1,14 = 0.63, 
P = .44), peripheral (S1: ß = 0.33, F1,14 = 1.55, P = .23; S2: ß = 0.09, 
F1,14 = 0.11, P = .75), and central (S1: ß = 0.38, F1,14 = 1.75, P = .28; S2: 
ß = 0.17, F1,14 = 0.18, P = .74) distances, as well as mean velocity (S1: 
ß = 0.47, F1,14 = 3.72, P = .07; S2: ß = 0.21, F1,14 = 0.62, P = .45).
OFo Performances of BA Mice Infused with BDNF 
into the Cerebellar Cortices
BA animals infused with 0.25 or 0.75 μg/μL PBS/side BDNF were 
significantly more active than BA animals bilaterally infused 
with PBS, and BA animals infused with 0.75 μg/μL PBS/side BDNF 
contacted the object significantly longest. Two-way ANOVA 
(group × session) on total distances (Figure  7A) revealed sig-
nificant group (F2,18 = 5.89, P = .01) and session (F1,18 = 5.47, P = .03) 
effects. The interaction (F2,18 = 1.61, P = .22) was not significant. 
Posthoc comparisons on group effect revealed that the BA-PBS 
group was less active in moving into the arena than the BA-BDNF 
Figure 5. Brain derived neurotrophic factor (BDNF) determination in avoiding (AV), balancing (BA), and approaching (AP) mice in the cerebellum (A), frontal cortex 
(B), hippocampus (C), and striatum (D). AP animals showed the highest cerebellar BDNF levels (*P = .05; **P = .01). Data are presented as means ± SEM and values are 
expressed in pg/g of wet weight (WW).
Figure  6. Linear regressions between cerebellar brain derived neurotrophic 
factor (BDNF) levels and behavioral data in avoiding (AV), balancing (BA), and 
approaching (AP) mice. A  positive significant association was found between 
cerebellar BDNF levels and conflict index of the Approach/Avoidance (A/A) 
Y-Maze (A). A  positive association was found between cerebellar BDNF levels 
and number of white choices in the session 2 (S2) of the A/A Y-Maze (B). Positive 
association was also found between cerebellar BDNF levels and contact times 
with the novel object in the Open Field (OFo) task (C). In the scatterplots are 
reported the linear fits (solid black lines), equations and R2.
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0.25 (P = .02) and BA-BDNF 0.75 (P = .01) groups. Two-way ANOVA 
(group × session) on peripheral distances (Figure 7B) showed no 
significant group effect (F2,18 = 1.41, P = .27), while session effect 
(F1,18 = 104.85, P < .00001) was significant. Interaction (F2,18 = 2.15, 
P = .15) was not significant. Two-way ANOVA (group × session) on 
central distances (mean ± SE: BA-PBS: - S1 9.4 ± 1.4, - S2 41.9 ± 0.7; 
BA-BDNF 0.25: - S1 11.5 ± 0.8, - S2 30.7 ± 2.6; BA-BDNF 0.75: - S1 
12.0 ± 1.5, - S2 40.9 ± 6.0) showed no significant phenotype effect 
(F2,12 = 2.07, P = .16), while session effect (F1,12 = 6522.00, P < .00001) 
was significant. Interaction (F2,12 = 3.02, P = .08) was not significant.
Two-way ANOVA (group × session) on velocity (Figure  7C) 
showed significant group (F2,18 = 6.03, P = .01) and session 
(F1,18 = 5.78, P = .03) effects. The interaction (F2,18 = 1.39, P = .27) was 
not significant. Posthoc comparisons on group effect revealed 
that the BA-PBS group was less rapid in moving into the environ-
ment than the BA-BDNF 0.25 (P = .02) and BA-BDNF 0.75 (P = .01) 
groups. One-way ANOVA on contact time with the novel object 
(Figure 7D) was significant (F2,18 = 6.16, P = .01), with the BA-BDNF 
0.75 group contacting the novel object more than the BA-BDNF 
0.25 and BA-PBS (always P = .02) groups.
A/A Y-Maze Performances of BA Mice Infused with BDNF into 
the Cerebellar Cortices
BA animals were infused with PBS or 0.25 or 0.75 μg/μL PBS/side 
BDNF before S3. When white choices were analyzed (Figure  8), 
a 2-way ANOVA (group x session) revealed no significant group 
effect (F2,12 = 2.90, P = .09), while the session effect (F1,12 = 12.26, 
P = .0002) was significant. The interaction (F4,24 = 2.81, P = .05) was sig-
nificant. Posthoc comparisons on significant interaction revealed 
no significant difference among groups in S1 and S2, while in S3, 
BA-BDNF 0.75 mice showed a number of white choices similar to 
the BA-BDNF 0.25 group (P = .72) and increased compared with the 
BA-PBS group (P = .05). The number of white choices was similar 
between BA-BDNF 0.25 and BA-PBS groups (P = .72).
OFo Performances of AV Mice Infused with BDNF into the 
Cerebellar Cortices
AV animals infused with 0.75 μg/μL PBS/side BDNF were signifi-
cantly more active and contacted the object significantly longer 
than AV animals bilaterally infused with PBS. Nonparametric 
analyses (Mann–Whitney U) on total distances (Figure  9A) 
revealed a significant difference between groups in S1 (U = 0, 
P = .02) but not in S2 (U = 8, P = 1). Mann–Whitney U test on periph-
eral distances (Figure  9B) revealed no significant difference 
between groups in S1 (U = 4, P = .25) and a significant difference 
in S2 (U = 0, P = .02). Mann–Whitney U test on central distances 
(mean ± SE: AV-PBS: - S1 4.0 ± 0.7, - S2 37.9 ± 5.2; AV-BDNF 0.75: 
- S1 6.9 ± 2.5, - S2 38.6 ± 1.8) revealed no significant differences 
between groups in S1 (U = 6, P = .56) and S2 (U = 8, P = 1). Mann–
Whitney U test on mean velocity (Figure  9C) revealed a sig-
nificant difference between groups in S1 (U = 0, P = .02) but not 
in S2 (U = 8, P = 1). Mann–Whitney U test on contact time with 
the novel object (Figure  9D) revealed a significant difference 
between groups (U = 1, P = .05).
As regards the AV-PBS group, Wilcoxon Signed Rank Test on 
total, peripheral, and central distances as well as mean veloc-
ity revealed significant differences between S1 and S2 (always 
P = .05) (Figure  9A-C). As regards the AV-BDNF 0.75 groups, 
Wilcoxon Signed Rank Test showed that peripheral and central 
distances were significantly different between S1 and S2 (always 
P = .05) (Figure 9B).
A/A Y-Maze Performances of AV Mice Infused with BDNF into 
the Cerebellar Cortices
AV animals were re-infused with PBS or 0.75  μg/μL PBS/side 
BDNF before S3. When white choices were analyzed (Figure 10), 
Mann–Whitney U test revealed no significant differences in S1 
(U = 2, P = .08) and S2 (U = 2, P = .08), while a significant difference 
between groups was found in S3 (U = 1, P = .04).
Figure 7. Open Field with novel object (OFo) performances of balancing (BA) brain derived neurotrophic factor (BDNF)-infused mice into the cerebellar cortices. Total 
distances (A), peripheral distances (B), and velocity (C) are reported. Animals infused with 0.25 (BA-BDNF 0.25) or 0.75 (BA-BDNF 0.75) μg/μL PBS/side BDNF were more 
active and rapid in exploring the environment in comparison to BA-PBS animals. The BA-BDNF 0.75 group contacted the novel object longer (D) than the BA-BDNF 0.25 
and BA-PBS (*P = .02) groups. Data are presented as means ± SEM.
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Friedman ANOVAs on white choices revealed significant dif-
ferences among S1, S2, and S3 in AV-PBS (P = .02) and AV-BDNF 
0.75 groups (P = .02).
Discussion
According to Elliot (2008), a subject characterized by a stable pre-
disposition of approach is explorative, curious, and seeks novelty. 
In fact, the AP mice were more active, rapid, and prone to explore 
the OFo arena by travelling longer distances in comparison with 
the BA and AV mice. Notably, the longest distances moved by the 
AP animals were not related to anxious behaviors, given that in all 
animals the percentages of peripheral and central distances were 
similar and decreased between S1 and S2. Even more importantly, 
the AP animals made contact with the novel object longer than 
BA and AV animals. To verify whether the basal BDNF levels were 
associated with a specific and stable predisposition to approach 
or avoidance, the BDNF levels in frontal cortex, hippocampus, stri-
atum, and cerebellum were evaluated in the 3 phenotypes. These 
analyses were made at a time-point distant from any behavioral 
testing to rule out any acute effect of the behavioral performance 
on BDNF levels. Interestingly, the AP mice showed the highest cer-
ebellar BDNF levels. Regression analyses indicated that the basal 
cerebellar BDNF levels were positively associated with the con-
flict index and white choices in the S2 of the A/A Y-Maze (when 
the aversive white environment was rewarded with the new pal-
atable food, thus making it worth risking to enter the “threaten-
ing and anxiogenic” white and lighted arm to obtain the reward). 
Furthermore, the cerebellar BDNF levels were positively associ-
ated with the contact times with the novel object placed in the 
“threatening and anxiogenic” central location of OFo arena. Our 
Figure 9. Open Field with novel object (OFo) performances of avoiding (AV) brain derived neurotrophic factor (BDNF)-infused mice into the cerebellar cortices. Total 
distances (A), peripheral distances (B), velocity (C), and contact time with the novel object (D) in session 1 (S1) and session 2 (S2) are reported. AV animals infused with 
0.75 μg/μL PBS/side BDNF (AV-BDNF 0.75) were more active (#P = .02) and rapid (#P = .02) in exploring the environment and contacted the object longer (*P = .05) than 
AV-PBS animals. In the AV-PBS group, total and peripheral distances and mean velocity were significantly different between S1 and S2 (*P = .05). In the AV-BDNF 0.75 
group, peripheral distances were significantly different between S1 and S2 (*P = .05). Data are presented as means ± SEM.
Figure  8. Approach/Avoidance (A/A) Y-Maze performances of balancing (BA) 
brain derived neurotrophic factor (BDNF)-infused mice into the cerebellar corti-
ces. The white choices were similar among groups in session 1 (S1) and session 
2 (S2), while the session 3 (S3) animals infused with 0.75 μg/μL PBS/side BDNF 
(BA-BDNF 0.75) showed a number of white choices similar to animals infused 
with 0.25 μg/μL PBS/side BDNF (BA-BDNF 0.25), but higher (*P = .05) than BA-PBS 
animals. Data are presented as means ± SEM.
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findings indicate that high cerebellar BDNF levels may represent 
a biomarker associated with stable predisposition to approach 
in its 2 components of exploration and search for novelty. These 
data are consistent with the observations that the endogenous 
concentrations and signaling of BDNF are associated with indi-
vidual differences in specific temperamental traits and disposi-
tions (Okuno et al., 2011; Duclot and Kabbaj, 2013; Yasui-Furukori 
et al., 2013). It was recently reported in healthy individuals a cou-
pling between anxiety temperamental traits and basal resting 
blood flow in fronto-limbic circuitry, determined in part by geneti-
cally mediated BDNF signaling (Wei et al., 2017). Furthermore, the 
individuals with at least 1 copy of the methionine allele in the 
BDNF gene show increased predisposition to anxious and depres-
sive behaviors (Gatt et al., 2009; Terracciano et al., 2010; Verhagen 
et al., 2010; Minelli et al., 2011). They also exhibit increased posi-
tive mood, lower perceived exertion, and increased motivation 
during exercise (Bryan et al., 2007, 2013; Caldwell Hooper et al., 
2014). By using low and high exploratory mice differing in their OF 
exploratory behavior (Kazlauckas, 2005), Kazlauckas et al. (2011) 
demonstrated that low exploratory mice show less retention in 
the inhibitory avoidance and lower BDNF levels in the hippocam-
pus (unfortunately the only brain area taken into account).
Nevertheless, it must be taken into account that BDNF is asso-
ciated not only with stable temperamental predispositions but 
also with the ongoing behavioral performance. Namely, exercise 
acutely increases BDNF levels (Adlard et  al., 2005; Ferris et  al., 
2007) and improves BDNF transcription (Oliff et al., 1998), thereby 
improving cognitive function (Berchtold et al., 2005, 2010). In par-
allel, single intraventricular injections of BDNF elicit anticatalep-
tic effects (Naumenko et al., 2012; Tikhonova and Kulikov, 2012; 
Kulikov et al., 2014), and BDNF administration attenuates behavio-
ral responses to stress (Schmidt and Duman, 2010; Ye et al., 2011).
Returning to the functions of BDNF in the cerebellar system, 
it has been demonstrated that BDNF transgene improves motor 
behavior in mutant mice characterized by severe cerebellar 
ataxia (Meng et  al., 2007), and that BDNF is implicated in the 
cerebellar long-term plasticity induced by the environmental 
enrichment (Angelucci et  al., 2009; Vazquez-Sanroman et  al., 
2013). It is noteworthy that the offspring of pre-reproductively 
enriched female rats show early maturation of complex motor 
abilities and increased cerebellar (and striatal) BDNF levels 
(Caporali et al., 2014).
Accordingly, after providing the indication that the individual 
differences in the inherent predisposition to approach were asso-
ciated with the cerebellar BDNF levels, in the present study it was 
needed to verify whether the cerebellar BDNF levels were caus-
ally related with the acute response of approach, in its double 
component of exploration and novelty-seeking. BDNF-infused 
BA and AV animals were more explorative, rapid, and approach-
ing toward novelty and reward than PBS-infused animals.
Overall, these data demonstrate that the approach behavior, 
in its 2 components of search for novelty and exploration, is a 
BDNF-mediated cerebellar process. The involvement of cerebellar 
system in the approach is an intriguing, but not unforeseeable, 
outcome. Besides motor coordination and learning, cerebellar sys-
tem has been functionally implied in cognitive, emotional, and 
motivational processes (Ito, 2006; Zhu et al., 2006; De Smet et al., 
2013; Laricchiuta et al., 2015), and more importantly (with regard 
to the present issue) in neural substrates of temperamental indi-
vidual differences (Wei et al., 2011; Picerni et al., 2013; Laricchiuta 
et al., 2014b; Petrosini et al., 2015, 2016). It was asserted that the 
cerebellum is the site where new and familiar stimuli are com-
pared to detect discordances, and where the novelty-related infor-
mation is processed more and more efficiently and adaptively 
(Restuccia et al., 2007; O’Reilly et al., 2008). In accordance with the 
cerebellar functions of error/novelty detection and internal model 
formation, Ito (2008, 2013) proposed that the cerebellum may alert 
the prefrontal cortex about the absence of internal models match-
ing the novel information, maintain the newly generated internal 
models, and incorporate them into routine schemes of thought. 
Also, its reciprocal connections with basal ganglia (Hoshi et  al., 
2005; Centonze et al., 2008; Rossi et al., 2008; Bostan et al., 2010) 
allow the cerebellum to influence reward-driven behavior and to 
process information related to motivational valence linked in turn 
to novelty detection and seeking. Not by chance, cerebellar BDNF 
infusions in AV and BA mice increased their approaching behavior 
toward the new palatable food. Crucially, in healthy individuals 
we found cerebellar volumes associated positively with Novelty 
Seeking scores and negatively with Harm Avoidance scores of the 
Temperament and Character Inventory by Cloninger (1986, 1987) 
(Picerni et al., 2013; Laricchiuta et al., 2014b).
Beyond seeking novelty, the cerebellar system has even 
been linked to the other component of approach, the explora-
tive behavior that, by requiring close integration between envir-
onmental (sensory) information and searching (motor) acts, 
involves the sensory-motor role classically attributed to cerebel-
lar networks. Several studies reported explorative deficits and 
spatial difficulties following cerebellar damage (Petrosini et al., 
1996; 1998; Noblett and Swain, 2003; Molinari et al., 2004). In par-
ticular, hemicerebellectomized rats exhibit reduced exploration 
in the OF (Mandolesi et  al., 2003), and cerebellar mutant mice 
(Rora(sg), Nna1(pcd-1J), nervous, Lurcher) exhibiting degener-
ation of cerebellar cortex or dentate nucleus or selective Purkinje 
cell loss display reduced exploration (Lalonde et al., 1988a, 1988b; 
Caston et al., 1998; Lalonde and Strazielle, 2003). Even in humans, 
the link between cerebellar function and exploration has been 
reported (Pierce and Courchesne, 2001; Kawa and Pisula, 2010). 
High scores in the exploratory excitability subscale of the nov-
elty seeking scale were related with micro-structural variations 
in cerebellar lobules IV, V, and VI (Picerni et al., 2013). However, 
despite the interest of these human findings, it is still to be 
clarified whether specific functions associated with individual 
differences determine the cerebellar regional structure or con-
versely, the different structure determines the specific func-
tions. Through the present experimental approach, we provide 
evidence for the existence of a link between BDNF-mediated 
Figure 10. Approach/Avoidance (A/A) Y-Maze performances of avoiding (AV) 
mice brain derived neurotrophic factor (BDNF) re-infused into the cerebellar 
cortices before session 3 (S3). The AV-BDNF 0.75 group showed a higher num-
ber of white choices than the AV-PBS group (*P = .04). Data are presented as 
means ± SEM.
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cerebellar processing and behaviors of exploration and novelty 
seeking. Even if an analysis of the possible BDNF action mecha-
nisms on cerebellar processing is beyond the scope of the present 
paper, it is important to note that the BDNF has been recognized 
as a crucial modulator of synaptic plasticity in the adult brain 
(Alkadhi, 2017). By binding the extracellular domain of tyrosine 
kinase B receptor, BDNF may enhance the quantal release of glu-
tamate and the functionality of NMDA receptors, acting pre- and 
postsynaptically, respectively (Lista and Sorrentino, 2010). These 
mechanisms influence various downstream signaling molecules 
involved in calcium entry and actin polymerization, improving 
structural plasticity and brain functionality (Vasuta et al., 2007).
In addition to the various events related to BDNF levels, 
including movement, physical activity, and exploration of a 
novel environment (Vaynman et al., 2004; Berchtold et al., 2010; 
Sleiman et  al., 2016), here we propose that the endogenous 
basal or acutely increased cerebellar BDNF levels promote the 
responses of exploration and novelty seeking, components that 
sustain the approach pattern.
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